Region Skane Skanes Universitetssjukhus
Region Skane Skanes Universitetssjukhus is recorded as a service provider in 9 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 9 of 9 trials · Latest update first
Contrast Strategy In Fenestrated EndoVascular Aneurysm Repair Randomized Control Trial
Sponsor Region Skane
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
PERELI - A phase 2, open label study of PEmigatinib and REtifanlimab in advanced dedifferentiated Liposarcoma
Sponsor Region Skane
- Start (EU)
- Latest update
- Estimated end
- Not reported
A multicenter prospective trial estimating the persistence of remission after stopping BCMA-CD3 bispecific antibody in multiple myeloma patients with major M-spike response by use MaldiTOF-based high sensitivity monitoring
Sponsor Vaestra Goetalandsregionen
- Start (EU)
- Latest update
- Estimated end
- Not reported
DiaPrecise, A Phase II Open Label Study to evaluate the safety and feasibility of intralymphatic administration of Diamyd® in individuals at risk for Type 1 diabetes carrying the HLA DR3-DQ2 haplotype
Sponsor Diamyd Medical AB
- Start (EU)
- Latest update
- Estimated end
- Not reported
Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors. An open-label, multi-center, randomized phase III trial comparing safety and efficacy of personalized vs non-personalized radionuclide therapy with 177Lu-DOTATOC
Sponsor Region Skane
- Start (EU)
- Latest update
- Estimated end
- Not reported
TRIANGLE - autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized European mcl network trial
Sponsor Klinikum der Universitaet Muenchen AöR
- Start (EU)
- Latest update
- Estimated end
Adjuvant instillations in intermediate risk NMIBC: A Study comparIng Gemcitabine and MitomYciN (SIGYN-trial)
Sponsor Region Skane
- Start (EU)
- Latest update
- Estimated end
- Not reported
Pivmecillinam with Amoxicillin/Clavulanic acid for Step Down Oral Therapy in Febrile UTIs Caused by ESBL-producing Enterobacterales
Sponsor Region Skane
- Start (EU)
- Latest update
- Estimated end
- Not reported
Positron emission tomography (PET) of patients with brain injury and athletes with concussion symptoms - Descriptive study of the tau tracer 18F-RO6958948
Sponsor Region Skane
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Region Skane Skanes Universitetssjukhus?
The 2026-10-09 snapshot links Region Skane Skanes Universitetssjukhus to 9 distinct CTIS trials. Recorded services include Clinical monitoring, Data management, Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Region Skane Skanes Universitetssjukhus?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Region Skane Skanes Universitetssjukhus conducted?
The linked trials record locations in 12 countries, including Sweden, Denmark, Norway, Belgium, Czechia. These are trial locations, not confirmed office locations or countries where Region Skane Skanes Universitetssjukhus delivered services.
What can this page tell me about Region Skane Skanes Universitetssjukhus's trial experience?
Browse 9 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Region Skane Skanes Universitetssjukhus. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Region Skane Skanes Universitetssjukhus